Crossmark

Erenumab Decreases Headache-Related Sick Leave Days and Health Care Visits: A Retrospective Real-World Study in Working Patients with Migraine

Published Online: 2021-12-10

Published Print: 2022-03

Authors

Autio, Henri https://orcid.org/0000-0002-0254-6846
Purmonen, Timo

Kurki, Samu

Mocevic, Emina

Korolainen, Minna A.

Tuominen, Samuli

Lassenius, Mariann I.

Nissilä, Markku
Funding

Funding for this research was provided by:

Novartis Finland Oy
License Information

Text and Data Mining valid from 2021-12-10

Version of Record valid from 2021-12-10
More Information

Article History

Received: 18 September 2021

Accepted: 16 November 2021

First Online: 10 December 2021

Document is current